Pharmaceutical pricing software company myDrugCosts is raising $200,000.

The offering is a mix of equity, options warrants and rights. So far, the Research Triangle Park-company has raised $75,000 from two investors, according to securities filings.

MyDrugCosts, a tenant of the First Flight Venture Center incubator, has developed a Software-as-a-Service offering that allows patients to look up drugs prices and compare them. Patients can look up prescription and generic drugs specific to their health plans in order to discuss pharmaceutical options with their doctors. The software is available for computers as well as smartphones.

CEO Dan Pollard gave additional details about the technology in this Q&A with WRAL Tech Wire last year.